Title |
Genetic and epigenetic alterations at secondary resistance after continued decitabine-based treatment of acute myeloid leukemia in the randomized phase II DECIDER trial |
|---|---|
Involved |
Inga Hund (Verfasser)
Maria Elena Hess (Verfasser) Andrieux Geoffroy (Verfasser) Julia Stomper (Verfasser)
Gabriele Greve (Verfasser)
Christoph Niemöller (Verfasser) Tobias Ma (Verfasser) David Uhl (Verfasser) Olga Grishina (Verfasser) Felicitas Thol (Verfasser) Michael Heuser (Verfasser) Gesine Bug (Verfasser) Martina Crysandt (Verfasser) Andreas Neubauer (Verfasser) Justus Duyster (Verfasser) Hartmut Döhner (Verfasser) Melanie Börries (Verfasser) Michael Lübbert (Verfasser) Heiko Becker (Verfasser) SpringerLink (Online service) (Sonstige) |
Published in |
Leukemia : normal and malignant hemopoiesis ; a peer-reviewed journal 39, 11, 7.10.2025, date:11.2025, Seite 2816-2819 |
Published |
2025 |
Language |
|
Country |
|
Topic |
|
Subject |
Public Health.
Internal Medicine. Intensive Care Medicine. Cancer Biology.
Oncology.
Hematology. |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2601052229537.391903382832 (URN) |
Record ID |
1385866004 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: